Q:  Won’t MuskokaPharma become an easy target for organized crime?
A:  No.  Our security measures, which will be approved by the RCMP, include a chain link fence topped with barbed wire around the perimeter of the building, plus dozens of video cameras with motion sensors that will be part of a 24-hour monitoring system making intrusion next to impossible.

Q:  What about the possibility of break-ins after hours?
A:  MuskokaPharma security personnel and other staff will be on site 24 hours a day, 365 days a year, including statuary holidays to not only monitor our security system but to keep an eye on the crops, some of which are under the grow lights continuously.

Q:  Are you concerned that some of your production will be diverted to the black market?
A:  No.  There will be over 100 video cameras with motion sensors inside our building making sure that staff are not able to divert our product.

Q:  Won’t people living downwind of the MuskokaPharma facility be bothered by the acrid smell of cannabis?
A:  No.  The air leaving the building will be cleaned by a combination of HEPA and charcoal filters.

Q:  Can patients walk in to MuskokaPharma and purchase their medical cannabis?
A:  No.  All product will be delivered by Canada Post or Purolator, with no on-site retail presence or cash exchanges.

Q:  How will MuskokaPharma product be shipped?
A:  Standard shipping will be a flat-rate of $13.50 to anywhere in Canada.

Q:  How do you plan on ensuring your product is of consistent high quality and safe to consume?
A:  Patient safety is our number one goal at MuskokaPharma.  We will be employing the latest scientifically-proven biosecure growing methods.  After harvest the plant material is carefully dried and analyzed by an independent third party laboratory approved by Health Canada.  All product is irradiated to remove any pathogens and is shipped either whole-cured or milled (to make consumption easier) depending upon individual patient preferences.

Q:  How do you make sure children cannot access your product?
A:  All MuskokaPharma products are packaged in child-proof containers that meet the Canadian Standards Association (CSA) and the Food and Drugs Act (FDA) specifications.

Q:  Do you use pesticides?
A:  No.  The plants are grown without the use of any pesticides. Our filtered irrigation water and growing media are monitored and tested daily.

Q:  Does smoking cannabis increase the risk of lung cancer?
A:  The jury is out on this claim, but we recommend that patients use a vaporizer which limits respiratory toxins by heating it to a temperature where the vapours form (typically around 180-190° Celsius), but below the point of combustion where noxious smoke and associated toxins (i.e., carcinogenic hydrocarbons) are produced (at near 230° Celsius).  Because vaporization can deliver doses of cannabinoids while reducing the user’s intake of carcinogenic smoke, it is considered to be a preferred and likely safer method of intake than smoking cannabis cigarettes or inhaling from a water pipe.  MuskokaPharma plans on selling vaporizers including the pocket-sized ASCENT by Da Vinci… http://www.davincivaporizer.com/

Q:  Will my medical plan cover medical cannabis?
A:  Medical insurance plans typically do not cover medical cannabis in Canada at this point in time; however, we are confident that it will be covered by provincial and private health plans in the near future as continued medical research confirms its efficacy.  It can be claimed in certain cases with Veterans Affairs (for PTSD), and can be claimed as a health deduction from personal income tax.

Q:  What is the proper medical cannabis dosage?
A:  Patients should use the minimum amount of medicine necessary to provide relief from their symptoms.  The average dose of medical cannabis is 1 to 3 grams per day when vaporized or smoked.  This number can be influenced by diet and lifestyle factors as well as a patient’s particular condition.

Q:  Is medical cannabis a recognized treatment? 

A:  Perhaps not “officially” recognized, but to state that there is no evidence of medical therapeutic benefit is to ignore thousands of published studies over the last few decades (not to mention tens of thousands of compelling anecdotal cases), which have collected a respectable and impressive amount of data attesting to the very promising therapeutic uses as well as highlighting the high safety profile and exceedingly low toxicity of cannabis.

Q:  Why are there are no clear indications for medical cannabis?

A:  The medical literature (and patient experience) supports an array of indications for a variety of ailments. Spasticity in multiple sclerosis, control of seizures in epilepsy, control of tremor in Parkinson’s disease, pain management in both malignant and chronic non-malignant diseases, chemotherapy-induced nausea and vomiting, appetite stimulation, management of chronic anxiety and post-traumatic stress disorder – to name just a few. The list goes on.

Q:  Isn’t cannabis addictive? 

A:  This is both misleading and overstated. As suggested by an Institute of Medicine report back in 1999, approximately 9% of general cannabis users may become dependent.  Compare this to dependency (addiction) risks of 32% for tobacco, 23% for heroin, 17% for cocaine and 15% for alcohol. It is hypocritical to deny patients easy access to cannabis while tobacco and alcohol are freely available, unquestionably harmful, pose a much greater addiction risk and are of zero medical benefit.  The simple truth is that the vast majority of patients can give up their cannabis with no ill effects, other than the return of symptoms for which they were originally taking the drug. Also of note is the fact that medical users are not looking to get high. They would prefer to alleviate their symptoms with a minimum of drug psychoactivity.

Q:  Aren’t the side effects of smoking (cannabis) still present, just like nicotine and cigarettes?

A:  Patients need not smoke their cannabis. Other delivery systems are available, such as vaporizing, or ingesting the cannabis extracts in the form of oils, tinctures or edibles which MuskokaPharma sees as the future of medicinal cannabis.

Q: Why is there are no real scientific data showing safety?

A:  It’s well supported in the scientific and medical literature that, with very few exceptions, cannabis is highly safe and remarkably low in toxicity – much safer, in fact, than aspirin or anti-inflammatories.  Apart from those with a history of schizophrenia or unstable heart disease, cannabis can be safely prescribed to the general adult population. There has never been a reported case of death resulting from a lethal overdose of cannabis and it is without doubt safer and decidedly less toxic than most, if not all, of the medications that are prescribed to the very sick patient population.  And yet, most medical colleges would have their members restrict cannabis prescriptions to a very small, select and specific subset of patients and only as a very last resort (if at all), assuming all else has failed, and even then, with a great deal of caution given the supposedly inherent “dangers” of this plant.